Menu
My Account
SignOut
Login
Join
About CASSS
Leadership
Staff
Mission and Vision
Career Center
Find a Job
Post a Job
Search CASSS
Meetings and Events
Multi-day Symposia
Bioassays
CE Pharm
Cell & Gene Therapy Products
CGTP Summit
Higher Order Structure
Mass Spectrometry
WCBP
CMC Strategy Forums
China
Europe
Japan
Latin America
North America
Discussion Groups
Case Studies/Workshops
Consultants' Network
Couch Chats
Partnership Opportunities
Exhibitors
Pharma Program Partners
Papers and Presentations
CASSS On Demand
News
Member Center
Member Resources
Volunteer: Get Involved!
Awards
The William S. Hancock Award for Outstanding Achievements in CMC Regulatory Science
CASSS Award for Outstanding Achievements in Separation Science
CE Pharm Award
Distinguished Fellows
Emerging Professionals
Emerging Leader in the Advancement of Scientific Knowledge Award
Next Generation Investigator Award
Frantisek Svec Fellowship
Hopkins Biotech Network Mentor Program
Join CASSS
CASSS Moments
Code of Conduct
NDA to BLA/Biosimilar – Are You Ready for the New Grey Zone?
Home
/
Papers and Presentations
/
Resource
In This Section
Papers and Presentations
CASSS On Demand
Share this article:
Roundtable 18 Notes: WCBP 2020
NDA to BLA/Biosimilar – Are You Ready for the New Grey Zone?
Related Files
NDA to BLA/Biosimilar – Are You Ready for the New Grey Zone?
